Envestnet Asset Management Inc Alnylam Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

  • $263 Billion
  • Q1 2024

A detailed history of Envestnet Asset Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 27,435 shares of ALNY stock, worth $6.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,435
Previous 27,279 0.57%
Holding current value
$6.82 Million
Previous $5.22 Million 21.47%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$146.51 - $198.2 $22,855 - $30,919
156 Added 0.57%
27,435 $4.1 Million
Q4 2023

Feb 13, 2024
BUY
$151.41 - $196.57 $410,169 - $532,508
2,709 Added 11.03%
27,279 $5.22 Million
Q3 2023

Nov 13, 2023
BUY
$170.77 - $211.65 $977,999 - $1.21 Million
5,727 Added 30.39%
24,570 $4.35 Million
Q2 2023

Aug 04, 2023
BUY
$185.01 - $212.05 $643,279 - $737,297
3,477 Added 22.63%
18,843 $3.58 Million
Q1 2023

May 11, 2023
BUY
$182.66 - $235.53 $233,804 - $301,478
1,280 Added 9.09%
15,366 $3.08 Million
Q4 2022

Feb 07, 2023
SELL
$185.53 - $241.31 $556,590 - $723,930
-3,000 Reduced 17.56%
14,086 $3.35 Million
Q3 2022

Nov 10, 2022
BUY
$138.54 - $232.0 $411,740 - $689,504
2,972 Added 21.06%
17,086 $3.42 Million
Q2 2022

Aug 03, 2022
SELL
$120.42 - $169.29 $2.08 Million - $2.93 Million
-17,306 Reduced 55.08%
14,114 $2.06 Million
Q1 2022

May 04, 2022
SELL
$127.18 - $173.91 $367,931 - $503,121
-2,893 Reduced 8.43%
31,420 $5.13 Million
Q4 2021

Feb 04, 2022
BUY
$159.56 - $209.29 $451,235 - $591,872
2,828 Added 8.98%
34,313 $5.82 Million
Q3 2021

Oct 07, 2021
BUY
$169.75 - $207.73 $251,230 - $307,440
1,480 Added 4.93%
31,485 $5.94 Million
Q2 2021

Aug 04, 2021
BUY
$128.63 - $176.89 $434,512 - $597,534
3,378 Added 12.69%
30,005 $5.09 Million
Q1 2021

May 04, 2021
BUY
$126.83 - $175.69 $1.65 Million - $2.28 Million
12,998 Added 95.37%
26,627 $3.76 Million
Q4 2020

Feb 02, 2021
SELL
$122.97 - $147.0 $3.07 Million - $3.67 Million
-24,953 Reduced 64.68%
13,629 $1.77 Million
Q3 2020

Oct 09, 2020
SELL
$121.19 - $165.49 $213,052 - $290,931
-1,758 Reduced 4.36%
38,582 $5.62 Million
Q2 2020

Jul 08, 2020
BUY
$104.21 - $156.44 $3.33 Million - $5 Million
31,940 Added 380.24%
40,340 $5.98 Million
Q1 2020

Apr 23, 2020
BUY
$93.12 - $133.99 $782,208 - $1.13 Million
8,400 New
8,400 $914,000

Others Institutions Holding ALNY

# of Institutions
585
Shares Held
104M
Call Options Held
2.82M
Put Options Held
1.75M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email